[print friendly]

celecoxib (CELEBREX)

• celecoxib (CELEBREX); meloxicam (MOBIC); rofecoxib (VIOXX); valdecoxib (BEXTRA)
  We list these drugs as Do Not Use drugs because they are no more effective than related drugs, most have not been shown to have a lower rate of ulcers than related drugs and some have been shown to cause heart disease.

• Arthritis and Inflammation [show all summaries]
• Salicylates and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) [show all summaries]

• Nonsteroidal Anti-Inflammatory Drugs Can Make Blood Pressure Hard to Control [show all summaries]
  (February 2009)
• Update on Drugs that Can Cause High Blood Potassium [show all summaries]
  (December 2008)
• Celecoxib (CELEBREX) May Double the Risk for Heart Attacks Compared to Older Arthritis Drugs [show all summaries]
  (May 2006)
• FDA Public Health Advisory - Arthritis Drug Valdecoxib (BEXTRA) Removed From Market; Major New Warnings for Other NSAIDs [show all summaries]
  (June 2005)
• Cutting Your Drug Bill While Reducing Your Risk Of Avoidable Adverse Drug Reactions: Six Examples [show all summaries]
  (February 2005)
• Alzheimer's Prevention Study Should Be Stopped [show all summaries]
  (October 2002)

• Letter to the FDA concerning Pfizer's 2 ½ minute television advertisement for Celebrex (HRG Publication #1803) [show all summaries]
• Bextra Ban a Good Step, But FDA Should Pull Celebrex Too (HRG Publication #1734) [show all summaries]
• Painkillers and Terrorism. Letter to the Editor of the New York Times on Cox 2 Painkillers (HRG Publication #1727) [show all summaries]
• Testimony to FDA on Dangers of Cox-2 Drugs (HRG Publication #1725) [show all summaries]
• Letter to FDA revealing heart dangers in an unpublished clinical trial of Celebrex (HRG Publication #1721) [show all summaries]
• Petition to remove the Cox-2 Inhibitors Celecoxcib (CELEBREX) and Valdecoxcib (BEXTRA) From the Market (HRG Publication #1720) [show all summaries]
• Vioxx, Other “Super Aspirins” Are Super Disasters – Other Cox-2 Alternatives Have Safety Problems Too (HRG Publication #1707) [show all summaries]
• Letter to HHS Secretary Tommy Thompson that raises ethical concerns about the “Alzheimer’s Disease Anti-Inflammatory Prevention Trial” (ADAPT) (HRG Publication #1637) [show all summaries]
• Testimony before the FDA Arthritis Drugs Advisory Committee on the Nonsteroidal Anti-Inflammatory Drugs Celecoxib and Rofecoxib (HRG Publication #1555) [show all summaries]
• Statement before the Food and Drug Administration's Arthritis Drugs Advisory Committee on the nonsteroidal anti-inflammatory drug celexocib. (HRG Publication #1465) [show all summaries]

• COX-2 Inhibitors Vioxx and Celebrex: Keep Staying Away--It Gets Worse [show all summaries]
  (March 2001)

SHOW secondary search results for celecoxib (CELEBREX)